NCT05988060

Brief Summary

The goal of this trial within cohorts study is to determine and compare physical performance, muscle strength, fatigue, quality of life, body composition, nutritional status, physical activity, treatment tolerability of radiotherapy (RT), chemoradiation (CRT) or bioradiation (BRT), and healthcare related costs in patients with head and neck cancer (HNC) with and without a 10 week physical exercise intervention (PEI) during RT, CRT or BRT ((C/B)RT). Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI twice a week for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. Researchers will compare patients who undergo the PEI with patients who did not undergo the PEI to see if there is difference in physical performance, muscle strength, fatigue, Quality of Life, body composition, nutritional status, physical activity, treatment tolerability of (C/B)RT , and healthcare related costs in patients with Head and Neck Cancer (HNC) with and without a 10 week Physical Exercise Intervention (PEI) during (C/B)RT).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P75+ for not_applicable head-and-neck-cancer

Timeline
6mo left

Started Nov 2022

Typical duration for not_applicable head-and-neck-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Nov 2022Nov 2026

Study Start

First participant enrolled

November 9, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2026

Expected
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

3 years

First QC Date

July 20, 2023

Last Update Submit

August 3, 2023

Conditions

Keywords

head and neck cancerchemo- or bioradiotherapyphysical exercise interventionphysical performancetrial within cohortsTwiCs

Outcome Measures

Primary Outcomes (1)

  • physical performance

    six minute walking test

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

Secondary Outcomes (12)

  • Muscle strength

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

  • Muscle strength

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

  • Muscle strength

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

  • Health Related Quality of Life

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

  • Health Related Quality of Life

    M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)

  • +7 more secondary outcomes

Study Arms (2)

Patients who were randomized in the PEI group and accepted the invitation

EXPERIMENTAL

The experimental intervention consist of a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT.

Other: Experimental Intervention

Patients who were not randomized in the PEI group

NO INTERVENTION

Patients will receive usual care.

Interventions

Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. The PEI consists of a 60 minutes intervention twice a week and will be supervised by a physiotherapist specialized in oncology. Patients who receive the intervention also have to do home-based aerobic and muscle strength exercises by themselves three times a week.

Also known as: Physical Exercise Intervention
Patients who were randomized in the PEI group and accepted the invitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with HNC who are scheduled for (C/B)RT,
  • ≥18 years of age,
  • sufficient Dutch writing and reading skills,
  • a Karnofsky performance status (KPS) \>60,
  • able to walk ≥60m without a mobility aid, and
  • no contraindication for physical activity as measured with the physical activity readiness questionnaire (PAR-Q).

You may not qualify if:

  • recurrence of HNC and/or
  • secondary HNC.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituut Verbeeten

Tilburg, North Brabant, 5042 SB, Netherlands

RECRUITING

Related Publications (1)

  • Kriellaars Y, Vermaire JA, Beugeling M, Poorter R, Drijvers J, Speksnijder CM. The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study. BMC Cancer. 2024 Apr 1;24(1):403. doi: 10.1186/s12885-024-12172-2.

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Yvette Kriellaars, Msc.

    Instituut Verbeeten

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Caroline Speksnijder, Dr.

CONTACT

Jorine Vermaire, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: In this study a TwiCs design will be used. The TwiCs design consists of an experimental intervention study within an observational longitudinal cohort. This design uses a staged-informed consent. Patients will be asked to participate in an observational longitudinal cohort study and will be informed about the design with the probability to be randomly invited for an experimental intervention which they can accept or refuse. When patients are willing to participate in the observational longitudinal cohort, an informed consent (IC) will be signed. Directly after cohort enrollment, all patients will be randomized.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 14, 2023

Study Start

November 9, 2022

Primary Completion

November 9, 2025

Study Completion (Estimated)

November 9, 2026

Last Updated

August 14, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations